SEARCH

SEARCH BY CITATION

References

  • Gaston, M.H., Verter, J.I., Woods, G., Pegelow, C., Kelleher, J., Presbury, G., Zarkowsky, H., Vichinsky, E., Iyer, R., Lobel, J.S., Diamond, S., Holbrook, C.T., Gill, F.M., Ritchey, K. & Falletta, J.M. for the Prophylactic Penicillin Study Group. (1986) Prophylaxis with oral penicillin in children with sickle cell anemia. A randomized trial. New England Journal of Medicine, 314, 15931599.
  • Geskus, R.B. (2011) Cause-specific cumulative incidence estimation and the fine and gray model under both left truncation and right censoring. Biometrics, 67, 3949.
  • Lees, C.M., Davies, S. & Dezateux, C. (2000) Neonatal screening for sickle cell disease. Cochrane Database of Systematic Reviews, Issue 1, CD001913.
  • Leikin, S.L., Gallagher, D., Kinney, T.R., Sloane, D., Klug, P. & Rida, W. (1989) Mortality in children and adolescents with sickle cell disease. Cooperative Study of Sickle Cell Disease. Pediatrics, 84, 500508.
  • Lucas, S.B., Mason, D.G., Mason, M. & Weyman, D. (2008) A sickle crisis?; a report of the National Confidential Enquiry into Patient Outcome and Death (NCEPOD). http://www.ncepod.org.uk/2008report1/Downloads/Sickle_report.pdf
  • Modell, B., Darlison, M., Birgens, H., Cario, H., Faustino, P., Giordano, P.C., Gulbis, B., Hopmeier, P., Lena-Russo, D., Romao, L. & Theodorsson, E. (2007) Epidemiology of haemoglobin disorders in Europe: an overview. Scandinavian Journal of Clinical and Laboratory Investigation, 67, 3969.
  • Olney, R.S. (1999) Preventing morbidity and mortality from sickle cell disease. A public health perspective. American Journal of Preventive Medicine, 16, 116121.
  • Peters, M., Fijnvandraat, K.W., van den Tweel, X.W., Garre, F.G., Giordano, G., van Wouwe, K., Rodrigues Pereira, R. & Verkerk, P.H. (2010) One third of the new paediatric sickle cell disease patients in the Netherlands is an immigrant and does not benefit from neonatal screening. Archives of Disease in Childhood, 10, 822825.
  • Powars, D.R., Chan, L.S., Hiti, A., Ramicone, E. & Johnson, C. (2005) Outcome of sickle cell anemia: a 4-decade observational study of 1056 patients. Medicine (Baltimore), 84, 363376.
  • Quinn, C.T., Rogers, Z.R., McCavit, T.L. & Buchanan, G.R. (2010) Improved survival of children and adolescents with sickle cell disease. Blood, 115, 34473452.
  • Riddington, C. & Owusu-Ofori, S. (2002) Prophylactic antibiotics for preventing pneumococcal infection in children with sickle cell disease. Cochrane Database of Systematic Reviews, Issue 3, CD003427.
  • Stuart, M.J. & Nagel, R.L. (2004) Sickle-cell disease. Lancet, 364, 13431360.
  • Telfer, P., Coen, P., Chakravorty, S., Wilkey, O., Evans, J., Newell, H., Smalling, B., Amos, R., Stephens, A., Rogers, D. & Kirkham, F. (2007) Clinical outcomes in children with sickle cell disease living in England: a neonatal cohort in East London. Haematologica, 92, 905912.
  • van den Tweel, X., Heijboer, H., Fijnvandraat, K. & Peters, M. (2006) Identifying children with sickle cell anaemia in a non-endemic country: age at diagnosis and presenting symptoms. European Journal of Pediatrics, 165, 581582.
  • Yanni, E., Grosse, S.D., Yang, Q. & Olney, R.S. (2009) Trends in pediatric sickle cell disease-related mortality in the United States, 1983–2002. Journal of Pediatrics, 154, 541545.